Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-19-076928
Filing Date
2019-03-15
Accepted
2019-03-15 17:26:35
Documents
14
Period of Report
2019-03-15

Document Format Files

Seq Description Document Type Size
1 6-K d701363d6k.htm 6-K 11654
2 EXHIBIT 1 d701363dex991.htm EX-99.1 1194627
3 EXHIBIT 2 d701363dex992.htm EX-99.2 79711
4 EXHIBIT 3 d701363dex993.htm EX-99.3 7604
5 GRAPHIC g701363dsp05.jpg GRAPHIC 4318
6 GRAPHIC g701363dsp07.jpg GRAPHIC 11946
7 GRAPHIC g701363dsp155.jpg GRAPHIC 37984
8 GRAPHIC g701363dsp163.jpg GRAPHIC 75794
9 GRAPHIC g701363dsp165_.jpg GRAPHIC 6339
10 GRAPHIC g701363g74h70.jpg GRAPHIC 2940
11 GRAPHIC g701363g97b78.jpg GRAPHIC 5757
12 GRAPHIC g701363img1.jpg GRAPHIC 2872
13 GRAPHIC g701363page019.jpg GRAPHIC 252255
14 GRAPHIC g701363page020.jpg GRAPHIC 122773
  Complete submission text file 0001193125-19-076928.txt   2015909
Mailing Address FOREST HOUSE, 58 WOOD LANE WHITE CITY LONDON X0 W12 7RZ
Business Address FOREST HOUSE, 58 WOOD LANE WHITE CITY LONDON X0 W12 7RZ 44 20 3829 6230
Autolus Therapeutics plc (Filer) CIK: 0001730463 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38547 | Film No.: 19686068
SIC: 2836 Biological Products, (No Diagnostic Substances)